Inspira Technologies Boosts ART100 Production Amid European Negotiations

Inspira Technologies Oxy BHN ( (IINN) ) just unveiled an update.

On June 5, 2025, Inspira Technologies announced it has scaled up production of its ART100 system in anticipation of demand from a European governmental authority, with which it is in advanced procurement negotiations. This strategic move aims to meet near-term delivery needs and reflects Inspira’s commitment to fast-track revenue generation and its emergence as a strategic public health supplier. The ART100 system, already used in U.S. clinical settings, is gaining recognition for critical care and emergency preparedness, supporting Inspira’s global rollout strategy.

The most recent analyst rating on (IINN) stock is a Buy with a $2.00 price target. To see the full list of analyst forecasts on Inspira Technologies Oxy BHN stock, see the IINN Stock Forecast page.

Spark’s Take on IINN Stock

According to Spark, TipRanks’ AI Analyst, IINN is a Underperform.

The overall stock score reflects significant financial instability, as indicated by ongoing losses and reliance on external funding. The technical analysis shows bearish sentiment, with the stock under pressure. Valuation is challenging due to negative earnings and lack of dividend yield, making the stock less appealing to investors.

To see Spark’s full report on IINN stock, click here.

More about Inspira Technologies Oxy BHN

Inspira Technologies Oxy B.H.N. Ltd. is a commercial-stage medical device company specializing in advanced respiratory support and real-time blood monitoring solutions. The company’s products include the FDA-cleared INSPIRA ART100 system, which is approved for cardiopulmonary bypass in the U.S. and ECMO procedures outside the U.S. Inspira is also developing the INSPIRA ART500 and the HYLA blood sensor, positioning itself as a significant player in the critical care and MedTech landscape.

Average Trading Volume: 471,752

Technical Sentiment Signal: Sell

Current Market Cap: $15.01M

For a thorough assessment of IINN stock, go to TipRanks’ Stock Analysis page.